Your browser doesn't support javascript.
loading
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Steffin, David H M; Muhsen, Ibrahim N; Hill, LaQuisa C; Ramos, Carlos A; Ahmed, Nabil; Hegde, Meenakshi; Wang, Tao; Wu, Mengfen; Gottschalk, Stephen; Whittle, Sarah B; Lulla, Premal D; Mamonkin, Maksim; Omer, Bilal; Rouce, Rayne H; Heczey, Andras; Metelitsa, Leonid S; Grilley, Bambi J; Robertson, Catherine; Torrano, Virginia; Lapteva, Natalia; Gee, Adrian P; Rooney, Cliona M; Brenner, Malcolm K; Heslop, Helen E.
Afiliação
  • Steffin DHM; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Muhsen IN; Department of Medicine, Houston Methodist Hospital, Houston, TX.
  • Hill LC; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Ramos CA; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Ahmed N; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Hegde M; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Wang T; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX; and.
  • Wu M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX; and.
  • Gottschalk S; Department of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN.
  • Whittle SB; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Lulla PD; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Mamonkin M; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Omer B; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Rouce RH; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Heczey A; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Metelitsa LS; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Grilley BJ; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Robertson C; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Torrano V; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Lapteva N; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Gee AP; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Rooney CM; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Brenner MK; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
  • Heslop HE; Center for Cell and Gene Therapy, Baylor College of Medicine-Texas Children's Hospital, Houston, TX.
Blood ; 140(1): 16-24, 2022 07 07.
Article em En | MEDLINE | ID: mdl-35325065

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article